M. Iwasaki

发表

Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma

S. Hirohashi, T. Shibata, N. Hiraoka, 2007, British Journal of Cancer.

Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma

N. Hiraoka, A. Kokubu, H. Ojima, 2011, British Journal of Cancer.

Endoscopic resection of early gastric cancer treated by guideline and expanded National Cancer Centre criteria

T. Gotoda, I. Oda, S. Seewald, 2010, The British journal of surgery.

Is surgical resection indicated for a solitary non-small cell lung cancer recurrence?

Y. Nishiwaki, K. Nagai, G. Ishii, 2006, The Journal of thoracic and cardiovascular surgery.

Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases

Y. Tachimori, S. Umemura, Y. Nakanishi, 2006, Modern Pathology.

A new histological classification for intra‐operative histological examination of the ductal resection margin in cholangiocarcinoma

A. Ochiai, T. Hasebe, H. Ojima, 2009, Cancer science.

Predictive factors for local recurrence of resected colorectal lung metastases.

Young Hak Kim, Y. Nishiwaki, A. Ochiai, 2005, The Annals of thoracic surgery.

Should Elderly Patients Undergo Additional Surgery After Non-Curative Endoscopic Resection for Early Gastric Cancer? Long-Term Comparative Outcomes

T. Gotoda, I. Oda, T. Kaltenbach, 2011, The American Journal of Gastroenterology.

Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer

Y. Kanai, N. Hiraoka, K. Shimada, 2013, British Journal of Cancer.

Tumor histology in lymph vessels and lymph nodes for the accurate prediction of outcome among breast cancer patients treated with neoadjuvant chemotherapy

T. Shibata, C. Shimizu, T. Kinoshita, 2009, Cancer science.

Clinicopathological and prognostic significance of EGFR , VEGF , and HER 2 expression in cholangiocarcinoma

S. Hirohashi, N. Hiraoka, H. Ojima, 2010 .

Modified primary tumour/vessel tumour/nodal tumour classification for patients with invasive ductal carcinoma of the breast

T. Shibata, T. Kinoshita, T. Hasebe, 2005, British Journal of Cancer.

Primary tumor/vessel tumor/nodal tumor classification of extrahepatic bile duct carcinoma.

A. Ochiai, T. Hasebe, T. Kinoshitá, 2008, Human pathology.

Important Histologic Outcome Predictors for Patients With Invasive Ductal Carcinoma of the Breast

T. Shibata, T. Kinoshita, H. Tsuda, 2011, The American journal of surgical pathology.

Atypical Tumor-stromal Fibroblasts in Invasive Ductal Carcinoma of the Breast

T. Shibata, T. Kinoshita, H. Tsuda, 2011, American Journal of Surgical Pathology.

p53 expression in tumor-stromal fibroblasts forming and not forming fibrotic foci in invasive ductal carcinoma of the breast

T. Shibata, T. Kinoshita, H. Tsuda, 2010, Modern Pathology.

p53 expression in tumor-stromal fibroblasts is closely associated with the nodal metastasis and outcome of patients with invasive ductal carcinoma who received neoadjuvant therapy.

T. Shibata, C. Shimizu, T. Kinoshita, 2010, Human pathology.

p53 expression in tumor stromal fibroblasts is associated with the outcome of patients with invasive ductal carcinoma of the breast

Takayuki Kinoshita, Tatsuhiro Shibata, T. Shibata, 2009, Cancer science.

Histopathologic factors significantly associated with initial organ-specific metastasis by invasive ductal carcinoma of the breast: a prospective study.

G. Ishii, T. Hasebe, T. Yokose, 2008, Human pathology.

Important prognostic histological parameters for patients with invasive ductal carcinoma of the pancreas

N. Shimizu, A. Ochiai, T. Hasebe, 2005, Cancer science.

Metaplastic carcinoma of breast

T. Shibata, T. Kinoshita, Y. Kanai, 2014 .

Atypical tumor-stromal fibroblasts in invasive ductal carcinomas of the breast treated with neoadjuvant therapy.

T. Shibata, C. Shimizu, T. Kinoshita, 2011, Human pathology.

Grading system for lymph vessel tumor emboli: significant outcome predictor for invasive ductal carcinoma of the breast.

T. Shibata, T. Kinoshita, T. Hasebe, 2010, Human pathology.

Grading system for lymph vessel tumor emboli: significant outcome predictor for patients with invasive ductal carcinoma of the breast who received neoadjuvant therapy

T. Shibata, C. Shimizu, T. Kinoshita, 2010, Modern Pathology.

Grading system for lymph vessel tumor emboli for prediction of the outcome of invasive ductal carcinoma of the breast.

G. Ishii, T. Hasebe, S. Imoto, 2008, Human pathology.

Histological factors for accurately predicting first locoregional recurrence of invasive ductal carcinoma of the breast

T. Shibata, T. Kinoshita, H. Tsuda, 2013, Cancer science.

Prognostic significance of mitotic figures in metastatic mammary ductal carcinoma to the lymph nodes.

T. Shibata, T. Kinoshita, H. Tsuda, 2011, Human pathology.

Accurate assessment of lymph vessel tumor emboli in invasive ductal carcinoma of the breast according to tumor areas, and their prognostic significance.

A. Ochiai, M. Fukayama, T. Hasebe, 2007, Human pathology.

Histological characteristics of tumor cells and stromal cells in vessels and lymph nodes are important prognostic parameters of extrahepatic bile duct carcinoma: a prospective study.

A. Ochiai, T. Hasebe, T. Kinoshitá, 2005, Human pathology.

Clinical impact of intraoperative histological examination of the ductal resection margin in extrahepatic cholangiocarcinoma

A. Ochiai, T. Hasebe, H. Ojima, 2010, The British journal of surgery.

Intraductal carcinoma component as a favorable prognostic factor in biliary tract carcinoma

S. Hirohashi, Y. Kanai, N. Hiraoka, 2009, Cancer science.

Metaplastic carcinoma of the breast.

T. Shibata, T. Kinoshita, Y. Kanai, 2010, Human pathology.

Intraductal carcinoma component as a favorable prognostic factor in biliary tract carcinoma

S. Hirohashi, Y. Kanai, N. Hiraoka, 2009, Cancer science.